Thiazide-induced dysglycemia: It's time to take notice

Expert Review of Cardiovascular Therapy

Volumn 6, Issue 10, 2008, Pages 1291-1294

  Cooper DeHoff, Rhonda M ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BENDROFLUMETHIAZIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHLORTALIDONE; DIPEPTIDYL CARBOXYPEPTIDASE; HYDROCHLOROTHIAZIDE; TRANDOLAPRIL; DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

BLOOD PRESSURE REGULATION; CLINICAL TRIAL; DIABETES MELLITUS; DISORDERS OF CARBOHYDRATE METABOLISM; DRUG INDICATION; DYSGLYCEMIA; EDITORIAL; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HUMAN; HYPERTENSION; HYPOKALEMIA; LONG TERM CARE; PREVALENCE; AGE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE; MIDDLE AGED;

AGE FACTORS; BLOOD GLUCOSE; DIABETES MELLITUS; DIURETICS; FEMALE; HUMANS; HYPERTENSION; MIDDLE AGED; SODIUM CHLORIDE SYMPORTER INHIBITORS;

EID: 59049095619     PISSN: 14779072     EISSN: 17448344     Source Type: Journal    
DOI: 10.1586/14779072.6.10.1291     Document Type: Editorial

References (24)

1. Wolff FW, Parmley WW, White K, Okun R. Drug-induced diabetes. JAMA 185, 568-574 (1963).
2. Chobanian AV, Bakris GL, Black HR et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42, 1206-1252 (2003).
3. Barzilay JI, Davis BR, Cutler JA et al. Fasting glucose levels and incident diabetes mellitus in older nondiabetic adults randomized to receive 3 different classes of antihypertensive treatment: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch. Intern. Med. 166, 2191-2201 (2006).
4. Davey Smith G, Bracha Y, Svendsen KH, Neaton JD, Haffner SM, Kuller LH. Incidence of Type 2 diabetes in the randomized multiple risk factor intervention trial. Ann. Intern. Med. 142, 313-322 (2005).
5. Verdecchia P, Reboldi G, Angeli F et al. Adverse prognostic significance of new diabetes in treated hypertensive subjects. Hypertension 43, 963-969 (2004).
6. Pepine CJ, Cooper-Dehoff RM. Cardiovascular therapies and risk for development of diabetes. J. Am. Coll. Cardiol. 44, 509-512 (2004).
7. Gupta AK, Dahlof B, Dobson J, Sever PS, Wedel H, Poulter NR. Determinants of new-onset diabetes among 19,257 hypertensive patients randomized in the Anglo-Scandinavian Cardiac Outcomes Trial - Blood Pressure Lowering Arm and the relative influence of antihypertensive medication. Diabetes Care 31, 982-988 (2008).
8. Cutler JA. Thiazide-associated glucose abnormalities: prognosis, etiology, and prevention: is potassium balance the key? Hypertension 48, 198-200 (2006).
9. Wright JT Jr, Harris-Haywood S, Pressel S et al. Clinical outcomes by race in hypertensive patients with and without the metabolic syndrome: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Arch. Intern. Med. 168, 207-217 (2008).
10. Verdecchia P, Angeli F, Reboldi G. New-onset diabetes, antihypertensive treatment, and outcome. Hypertension 50, 459-460 (2007).
11. Zillich AJ, Garg J, Basu S, Bakris GL, Carter BL. Thiazide diuretics, potassium, and the development of diabetes: a quantitative review. Hypertension 48, 219-224 (2006).
12. Carter BL, Einhorn PT, Brands M et al. Thiazide-induced dysglycemia: call for research from a working group from the national heart, lung, and blood institute. Hypertension 52, 30-36 (2008).
13. Helderman JH, Elahi D, Andersen DK et al. Prevention of the glucose intolerance of thiazide diuretics by maintenance of body potassium. Diabetes 32, 106-111 (1983).
14. Cooper-Dehoff R, Cohen JD, Bakris GL et al. Predictors of development of diabetes mellitus in patients with coronary artery disease taking antihypertensive medications (findings from the International Verapamil SR-Trandolapril Study [INVEST]). Am. J. Cardiol. 98, 890-894 (2006).
15. American Diabetes Association. Standards of medical careto diabetes-2007. Diabetes Care 30 (Suppl. 1), S4-S41 (2007).
16. American Heart Association. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106, 3143-3421 (2002).
17. Lakka HM, Laaksonen DE, Lakka TA et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288, 2709-2716 (2002).
18. Hunt KJ, Resendez RG, Williams K, Haffner SM, Stern MP. National Cholesterol Education Program versus World Health Organization metabolic syndrome in relation to all-cause and cardiovascular mortality in the San Antonio Heart Study. Circulation 110, 1251-1257 (2004).
19. Black HR, Davis B, Barzilay J et al. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). Diabetes Care 31, 353-360 (2008).
20. Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA 290, 1884-1890 (2003).
21. Lindholm LH, Ibsen H, Borch-Johnsen K et al. Risk of new-onset diabetes in the Losartan Intervention For Endpoint reduction in hypertension study. J. Hypertens. 20, 1879-1886 (2002).
22. Mancia G, De Backer C, Dominiczak A et al. 2007 Guidelinesfor the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur. Heart J. 28, 1462-1536 (2007).
23. American Association of Clinical Endocrinologists. Medical guidelines for clinical practice for the diagnosis and treatment of hypertension. Endocr. Pract. 12, 193-222 (2006).
24. Sever P. New hypertension guidelines from the National Institute for Health and Clinical Excellence and the British Hypertension Society. J Renin Angiotensin Aldosterone Syst. 7, 61-63 (2006).